This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hidradenitis Suppurativa
and you are
between 18 and 99
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This study investigates efficacy, safety and pharmacokinetics of adalimumab in Japanese subjects with moderate to severe hidradenitis suppurativa (HS).

Provided treatments

  • Drug: adalimumab

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02904902. The sponsor of the trial is AbbVie and it is looking for 15 volunteers for the current phase.
Official trial title:
A Phase 3 Multicenter, Open-label, Single Arm Study of the Safety and Efficacy of Adalimumab in Japanese Subjects With Moderate to Severe Hidradenitis Suppurativa